In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.
about
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.Association of γH2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer.Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases.3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
P2860
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
In real life, one-quarter of p ...... ands Breast Cancer Consortium.
@en
type
label
In real life, one-quarter of p ...... ands Breast Cancer Consortium.
@en
prefLabel
In real life, one-quarter of p ...... ands Breast Cancer Consortium.
@en
P2093
P2860
P356
P1433
P1476
In real life, one-quarter of p ...... ands Breast Cancer Consortium.
@en
P2093
A J van de Wouw
D J A Lobbezoo
F P J Peters
F van den Berkmortel
J M G H van Riel
M W Dercksen
N A J B Peters
P G M Peer
R J W van Kampen
P2860
P304
P356
10.1093/ANNONC/MDV544
P577
2015-11-16T00:00:00Z